Infectious Diseases – News and Features

Researchers at Swiss Federal Institute of Technology are using two customized Tecan Freedom EVO® 200 liquid handling workstations to silence 7,000 mammalian genes.

Copernicus shows that the methods used to produce DNA nanoparticles were also very effective when applied to siRNA.

The studies will enable Can-Fite to treat rheumatoid arthritis patients in future Phase III clinical trials for prolonged periods of time as required in various Phase III studies.

In startling new imagery, a drug developed by NanoViricides dismantles a virus particle in a visual demonstration of the mechanism of action of nanoviricides in vitro.

A study demonstrating therapeutic utilization of human stem cells, including application to X-SCID was presented at the 10th ASGT meeting.

The long-term goal of the initiative is to shed light on the causes of complex disorders and diseases and develop new approaches for treating them.

The Company will make multiple presentations regarding its electroporation-mediated DNA delivery technology at the meeting.

LabCorp enters a supply agreement to offer FDA approved COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test from Roche Diagnostics.

Data from a clinical study of DNA-based prostrate cancer demonstrated that Inovio’s DNA delivery technology enhanced the potency of the gene-based vaccine.

BioFocus DPI has signed agreements with Cancer Research Technology Ltd and the University of Rochester Medical Center.